The Challenge: Staying updated with the ever-changing competitive landscape in asthma.
A respiratory brand team of a large pharmaceutical company asked LucidQuest΄s help to identify key competitor plans and analyze the future landscape in asthma (including new competitors and mechanisms of action (MoA)).
The Action: Extensive primary research, focused on KOLs and competitor sources.
LucidQuest gathered vital intelligence from competitors and key opinion leaders (KOLs) to gain insight into the clinical development programs of current and future players.
The Result: Empowered client, informed CDP and go/no-go decisions.
The client acquired an up-to-date pipeline view (centered around competitor assets’ mechanisms of action) and a view of the future landscape and the relative positioning of competitors.
Subsequently, the client successfully integrated the insights we provided into their clinical development program development and used intelligence to support informed go/no-go decisions.
The comprehensive view of the future landscape and the relative positioning of competitors, coupled with LucidQuest’s strategic intelligence, empowered the client to navigate their development pathways with greater clarity and precision.
#respiratory #CPD #asthma #competitiveintelligence #ourwork #casestudy